Articles On Polynovo (ASX:PNV)

Summary The ASX 200 was trading slightly higher during the mid-market session, following the details of the $US1.9 trillion stimulus plan by the US government to boost the economy. While ASX All Technology Index was up 1.128 per cent,...

The S&P/ASX 200 Index (ASX: XJO) has dropped back from its highs but is still on course to record a gain. In afternoon trade the benchmark index is up 0.25% to 6,731.9 points. Four shares that have failed to follow the market higher to...

At lunch on Friday the S&P/ASX 200 Index (ASX: XJO) is on course to end the week on a positive note. The benchmark index is currently up 0.4% to 6,741 points. Here’s what is happening on the market today: Afterpay hits record high. The...

Summary ASX 200 recovered after slipping in the early trade, with healthcare and technology sectors pulling the ASX chords. ASX rebound by driven by Pro Medicus (11.01per cent), Polynovo (5.2 per cent), Afterpay (7.46 per cent), and Zi...

In just a few weeks, nearly $1 billion has been wiped from the market capitalisation of medical device manufacturer PolyNovo Ltd (ASX: PNV). The PolyNovo share price reached new highs late last year, pushing over the $4 mark. Since then, th...

The Polynovo Ltd (ASX: PNV) share price was one of the best performing ASX 200 healthcare shares in 2020, running from $1.97 to $3.88. But when the company’s share price started to turn in the wrong direction, it fell and it fell fast.  I...

On 13th January 2021, the equity market of Australia settled in green as ASX200 rose by 0.11% to 6686.60. On the same day, Energy and Consumer Cyclicals sectors rose by 4.26% and 0.46%, respectively. Sector Summary (Source: Refinitiv, Th...

The S&P/ASX 200 Index (ASX: XJO) went up by 0.1% today to 6,687 points. Here are some of the highlights from the ASX: Premier Investments Limited (ASX: PMV) The Premier Investments share price was the best performer in the ASX 200 tod...

At lunch on Wednesday the S&P/ASX 200 Index (ASX: XJO) is on course to make it three days of declines in a row. The benchmark index is currently down 0.3% to 6,660.7 points. Here’s what has been happening on the market today: Premier I...

In morning trade the S&P/ASX 200 Index (ASX: XJO) is on course to record another decline. At the time of writing, the benchmark index is down 0.15% to 6,667.8 points. Four shares that have fallen more than most today are listed below....

The S&P/ASX 200 (ASX: XJO) is expected to take a slight backwards step when the market opens on Wednesday according to the latest SPI futures. Here’s what ASX investors need to know. ASX 200 slide continues, Altium flags weakness The AS...

At the close of trading session on 12th January 2021, the equity market of Australia ended in red as ASX 200 fell by 0.27% to 6679.10. Academic & Educational Services sector rose by 1.21% and financials sector rose by 0.69%. Sector S...

The S&P/ASX 200 Index (ASX: XJO) dropped by 0.30% to 6,679 points today. Here are some of the highlights from the ASX: ARB Corporation Limited (ASX: ARB) Four-wheel drive accessory company ARB gave a market update today regarding its...

Summary Market is reacting adversely to the trading update provided by PolyNovo for H1 FY21.  The company said first-half FY21 sales were 31% higher compared to H1 FY20.  PolyNovo Limited (ASX:PNV) has reported a trading update for...

At lunch on Tuesday the S&P/ASX 200 Index (ASX: XJO) is defying the declines on Wall Street and pushing higher. The benchmark index is currently up 0.4% to 6,722.6 points. Here’s what has been happening on the market today: Altium guid...

In late morning trade the S&P/ASX 200 Index (ASX: XJO) is on course to bounce back from yesterday’s decline. The benchmark index is currently up 0.2% to 6,709.8 points. Four shares that have failed to follow the market higher today are...

Medical technology company PolyNovo (ASX: PNV) recorded 31 per cent sales growth in the first half of FY21 despite its hospital clients getting waylaid by COVID-19, with 35 new accounts opened for its skin healing patches. But shares in t...

The Polynovo Ltd (ASX: PNV) share price is down 5% after giving a HY21 update. Polynovo is a business involved in helping regenerating skin that’s been lost through extensive surgery or buns. NovoSorb is a range of bio-resorbable polymers t...

12 Dec 2021 - PolyNovo (ASX:PNV) has reported an increase in sales of 31 per cent in the first half of the 2021 financial year.

The PolyNovo Ltd (ASX: PNV) share price is on the move on Tuesday following the release of a trading update. In morning trade the medical device company’s shares are down a disappointing 10% to $3.04. What did PolyNovo announce? PolyNovo’s...

Stocks turne down; Super Retail, ARB surge; Polynovo dives

With the S&P/ASX 200 Index (ASX: XJO) moving higher today, up 1.59% at the time of writing, it draws interest to the shares bucking the trend. These 3 mid-cap shares have had a rough month and are hitting 1-month lows today. Which mid-...

If 2020 taught us anything, it was the importance of quality healthcare. The COVID-19 pandemic put unprecedented demand on global health services, with many providers rising to the challenge. Healthcare has long been seen as a defensive in...

The S&P/ASX 200 Index (ASX: XJO) dropped by 1.1% today to 6,607 points. Over in US political news, it seems the US Democratic Party is poised to win the US senate with wins in Georgia. Here are some of the highlights from the ASX: Oil...

The PolyNovo Ltd (ASX: PNV) share price was one of the best performers on the S&P/ASX 200 Index (ASX: XJO) in 2020. Over the 12 months, the medical device company’s shares almost doubled in value with a 97% gain. Why did the PolyNovo s...

The onset of a major pandemic last year created tailwinds for many ASX 200 healthcare shares that supported the global effort to tackle COVID-19. This accelerated the earnings of many ASX 200 healthcare shares, including familiar names su...

The Avita Medical Inc (ASX: AVH) share price has lost more than 60% over one year, despite the company showing growth and delivering record revenues in FY20. Is the Avita share price a good buy at this level, and what of its prospects for...

Two key ASX sectors that I’ll be researching for growth opportunities in 2021 are healthcare and technology. Relative to many other countries, Australia boasts world-class healthcare infrastructure and medical research with state-of-the-art...

I wouldn’t typically expect shares in a company with a market capitalisation of $2 billion to rocket over 80% in just a few months. I’m of course talking about medical technology company PolyNovo Ltd (ASX: PNV), a leader in wound care techn...

The onset of COVID-19 has seen ASX biomedical shares become involved in combatting the pandemic. Some companies are focused on treatments and equipment and others on the generation of a vaccine. This has translated to strong share price ap...

At lunch on Monday the S&P/ASX 200 Index (ASX: XJO) looks set to start the shortened week with a disappointing decline. The benchmark index is currently down 0.4% to 6,648.9 points. Here’s what has been happening on the market today: P...

Summary In 2020, the stock market stayed highly volatile due to the negative impact of the coronavirus pandemic.  However, the healthcare sector remained relatively stable and managed to give good returns to the investors. CogState, P...

The healthcare sector has been an interesting one to watch in 2020. Almost all ASX shares have been defined by how they have been affected, and perhaps reacted to, the coronavirus pandemic in 2020. But healthcare, especially so, for obviou...

The S&P/ASX 200 Index (ASX: XJO) has delivered its 5th straight week of gains. While many ASX 200 shares are still well below their pre-COVID-19 price levels, some are not only setting year-to-date highs on the ASX, they’re breaking ou...

In late morning trade the S&P/ASX 200 Index (ASX: XJO) is on course to start the month on a positive note. At the time of writing, the benchmark index is up 0.7% to 6,565.3 points. Four shares that are climbing more than most today are...

The S&P/ASX Healthcare index finished November just 2.72% higher compared to the 9.5% surge in the S&P/ASX 200 Index (ASX: XJO). Sectors that benefitted from lockdowns including technology, ecommerce and consumer staples underperfo...

ShareCafeAustralia…One Hour In…ASX up 33 points ASX200 up 33 points (0.5%) to 6551. AUB (-1.6%); will acquire 360 Underwriting Solutions for $127m. Collins Foods (+4.2%); 1H profit +15%.   Strong result. Domino’s Pizza (+11%); Investor Day...

The PolyNovo Ltd (ASX: PNV) share price has continued its positive run on Monday. In afternoon trade the medical device company’s shares are up over 4% to $3.22. This leaves the PolyNovo share price trading just short of its record high of...

There are around 2,185 stocks on the ASX, but here are just three ASX growth shares I’m really liking at the moment. Objective Corporation Objective Corporation Limited (ASX: OCL) is a multinational software provider with a suite of produc...

The S&P/ASX 200 Index (ASX: XJO) rose by 0.25% to 6,547 points today. Here are some of the highlights from the ASX: SEEK Limited (ASX: SEK) The company released an update about FY21 today at its annual general meeting (AGM). It said...

The Polynovo Ltd (ASX: PNV) share price has lifted higher today on news of an international expansion. Polynovo advised the ASX it was expanding operations into multiple new countries with its ongoing partner, PolyMedics Innovations (PMI)....

Polynovo Ltd (ASX: PNV) shares are on watch today after the company announced expansion in Europe. NovoSorb is a range of bio-resorbable polymers that can be produced in many formats, including film, fibre, foam and coatings. NovoSorb BTM i...

Shares in S&P/ASX 200 (ASX: XJO) company PoloNovo Ltd (ASX: PNV) have rallied in recent months following a string of positive announcements. The last time I wrote about PolyNovo in September, shares were trading around $2.20. In less th...

In afternoon trade the S&P/ASX 200 Index (ASX: XJO) remains suspended following a system upgrade failure at the Australian stock exchange. Prior to the pause, the benchmark index was up a solid 1.2% to 6,484.3 points. Four shares that...

Summary ASX 200-listed PolyNovo Limited receives FDA green light for its BARDA supported pivotal trial IDE. The Company is set to commence a clinical trial at 20 sites to recruit 150 patients. Polynovo estimate recruitment will start e...

The Polynovo Ltd (ASX: PNV) share price is soaring higher today. This comes after the company announced an approval of a pivotal trial investigation device exemption (IDE). During mid-morning trade, shares in the medical device company rea...

In early afternoon trade the S&P/ASX 200 Index (ASX: XJO) is on course to finish the week on a disappointing note. The benchmark index is currently down 0.5% to 6,386.8 points. Four shares that have not let that hold them back are list...

On Thursday the S&P/ASX 200 Index (ASX: XJO) ran out of steam and ended its impressive winning streak. The benchmark index gave back its morning gains and fell 0.5% to 6,418.2 points. Will the market be able to bounce back from this on...

S&P/ASX 200 Index (ASX: XJO) healthcare shares have surprisingly underperformed other sectors such as energy, consumer staples, financials and technology in October. This likely follows a prior period of outperformance due to COVID-rel...

The PolyNovo Ltd (ASX: PNV) share price shot up 8.73% yesterday after announcing Taiwan FDA approval. PolyNovo is a medical device company specialising in the development of dermal regeneration products. PNV share price Source: Rask Media P...